Azenta (AZTA) vs LeMaitre Vascular (LMAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azenta (AZTA) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 11.7% versus a loss of 9.5%. Over five years, LMAT leads with a +48.6% price change compared with -65.2% for AZTA. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $1.58 billion), about 1.2 times the size.
On valuation, LeMaitre Vascular trades at a lower forward P/E (25.1x vs 65.2x for Azenta). LeMaitre Vascular pays a dividend yielding 1.13%, while Azenta does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTA | LMAT |
|---|---|---|
| Share price | $36.00 | $79.64 |
| Market cap | $1.58B | $1.82B |
| 1-day change | +0.31% | +0.42% |
| YTD return | +8.24% | -1.80% |
| 1-year return | +11.70% | -9.54% |
| 5-year return | -65.20% | +48.64% |
| P/E ratio (TTM) | — | 27.94 |
| Forward P/E | 65.16 | 25.05 |
| EPS (TTM) | $-2.47 | $2.85 |
| Dividend yield | 0.00% | 1.13% |
| Annual dividend | $0.00 | $0.90 |
| 52-week high | $46.41 | $118.01 |
| 52-week low | $15.93 | $78.22 |
| Distance from 52-week high | -22.43% | -32.51% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +2.78% | +34.35% |
| Average volume | 875.72K | 330.14K |
| Shares outstanding | 43.81M | 22.87M |
| Employees | 2,900 | 646 |
| Sector | Technology | Healthcare |
| Industry | Industrial Machinery/Components | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AZTA has outperformed LMAT by 21.2 percentage points over the past year.
- LeMaitre Vascular offers a meaningfully higher dividend yield (1.13% vs 0.00%).
- The two companies sit in different sectors: Azenta in Technology and LeMaitre Vascular in Healthcare.
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Technology · Industrial Machinery/Components · 2,900 employees
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Healthcare · Medical Instruments & Supplies · 646 employees
AZTA vs LMAT FAQ
Which is bigger, Azenta or LeMaitre Vascular?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $1.58B for Azenta (AZTA).
Which stock has performed better over the past year, AZTA or LMAT?
AZTA returned +11.70% over the past 12 months, compared with -9.54% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Azenta or LeMaitre Vascular?
LeMaitre Vascular pays a dividend yielding 1.13%, while Azenta does not currently pay a regular dividend.
Are Azenta and LeMaitre Vascular in the same industry?
No. Azenta is in the Technology sector, while LeMaitre Vascular is in Healthcare.